Retrovirus from the HIV type O and its use (MVP-2901/94)

US6974866B2 · kind B2 · utility

Assignee

• Dade Behring Marburg GmbH · DE

Inventors

• Hans-Peter Hauser · Marburg, DE
• Stefan Knapp · Marburg, DE
• Stefan Brust · Marburg, DE
• Lutz G. Gürtler · Munich, DE
• Josef Eberle · Freising, DE
• Lazare Kaptue · Brüggen, DE
• Léopold Achenqui Zekeng · Brüggen, DE

Key dates

• Filing date: Feb 4, 2003
• Grant date: Dec 13, 2005
• Expiry date: Mar 25, 2023

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S530/812
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A novel HIV type O immunodeficiency virus is disclosed which has the designation MVP-2901/94 and which has been deposited with the European collection of animal Cell Cultures (ECACC) under No. V 950121601. The characteristic antigens which can be obtained from the virus and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the partial DNA and amino acid sequences of the virus.